Innovation Pharmaceuticals Inc (IPIX)

[tombrady12nh]

From post 139169
compound. In addition to its p53 restorative property, Welsh and his colleague’s at MD Anderson have found that Kevetrin also behaves like a checkpoint inhibitor. Two PD1-inhibiting drugs, Keytruda and Opdivo, were approved in 2015 for treatment of metastatic lung cancer and while they are effective approximately 20% of the time, they each cost about $150,000 annually.